Clinical Trial Update: A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a novel gene therapy in patients with relapsed and refractory multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Kelonia Therapeutics, Inc. | Conditions: Multiple Myeloma in Relapse, Myeloma Multiple | Phase 1 | Status: RECRUITING